Podcasts about seizures

Unlocking Peak Health & Performance with Zoe KarliWhat if the key to optimizing your health, energy, and performance lies in precision? In this episode, I sit down with Zoe Karli, founder of Zeta Body and president of Greyledge Technologies, to discuss how targeted lifestyle choices and high-quality supplements can transform your well-being.Zoe shares her personal journey of managing grand mal (tonic-clonic) seizures through exact medication formulations—where even the slightest variation could impact effectiveness. This understanding of precision is reflected in Zeta Body supplements.  Alongside her husband, Dr. David Karli, a world-renowned regenerative medicine specialist, Zoe is reshaping the future of health. Together, they combine science and passion to empower people to unlock their full potential.Connect with Zoe Karli:

On this episode of Talk About It, we break out the Gold Jacket to chat with Alan Faneca, retired NFL offensive lineman and NFL Hall of Fame Inductee! Alan and Greg have become friends through advocacy for epilepsy awareness over the years, because Alan was diagnosed with epilepsy when he was a teenager and played at the highest levels of football with the condition. He also has a daughter with a rare form of epilepsy, so this cause is really close to his heart. Ironically, Nick also has a connection to Alan through his time with the Pittsburgh Steelers and hosting events together, so this is really a friend reunion show! They discuss his diagnosis, how his family helps him deal with the condition, going through the process again with his daughter, and - of course - his induction into the NFL Hall of Fame in Canton, OH. This is an episode that you are seriously not going to want to miss! The Talk About It podcast is excited to be sponsored in part by Neurelis. The Talk About It podcast is excited to also be sponsored in part by Seizures Are Signs — dedicated to educating families on the importance of early and specific diagnosis by providing an assessment to help get the conversation started, educational information, stories from families who have found a diagnosis, links to advocacy groups, and more. For more information, go to SeizuresAreSigns.com. Seizures are Signs is made available by Jazz Pharmaceuticals.

In this episode of The Jerich Show, Erich Kron and Javvad Malik dive headfirst into the week's most curious, cringeworthy, and critical cybersecurity stories. First up: a global honeypot powered by over 5,300 compromised Cisco devices—courtesy of the ViciousTrap botnet. Then, it's schadenfreude central as the developers of DanaBot malware accidentally infect themselves. Karma, meet keyboard. We'll also unpack Europol's massive takedown of ransomware infrastructure, which led to the seizure of 300 servers and €3.5 million in crypto. Not to be outdone, two ATM heist suspects made their arrest even easier... by taking selfies mid-crime. And finally, the UK's NCSC shows us how to securely retire old tech—because tossing servers in the skip just isn't secure policy. Join Erich and Javvad for sharp takes, security snark, and the cybersecurity fails you'll want to learn from (or at least laugh at).

In this conversation, Joel Evan interviews Don Dillon, the CEO and founder of Sound Foods, who shares his remarkable journey from a Navy veteran facing severe health challenges to an innovator in the health and wellness market. Don discusses the unique technology behind his nutrient-rich food bars, which utilize ultrasonic technology and microencapsulation to preserve nutrients and enhance flavor. He emphasizes the importance of clean ingredients and the potential for his products to address nutritional deficiencies in various populations, including military personnel and those in need globally. The conversation also touches on the misconceptions surrounding nutrition, the impact of toxins, and the future of food innovation.Chapters00:00 Introduction to Don Dillon and Sound Foods03:04 Don's Journey: From Navy to Health Innovator06:00 The Impact of Seizures and Recovery Journey09:00 The Birth of Sound Foods and Healthy Snack Bars11:45 Innovative Technology in Food Production15:00 Microencapsulation and Nutrient Preservation18:05 Future of Food: Integrating Supplements into Snacks19:54 Innovative Nutritional Solutions26:35 Addressing Global Nutritional Needs32:33 Personal Health Journeys and Insights34:17 Challenging Nutritional Myths39:28 Future of Food Technology

Last year, both Belgium and the Netherlands, home to the key ports of Antwerp-Bruges and Rotterdam, reported a dramatic decline in the volume of cocaine seized. As the traditional gateways into Europe for legal as well as illegal cargo, this is surely cause for celebration, or at the very least a pat on the back. The only problem? Seizures in Portugal, Italy, Greece and other southern European countries increased. Which begs the question, how on earth do you stop smuggling? Lloyd's List reporter Joshua Minchin again speaks to four experts at the very frontline in the fight against smuggling to understand how public-private cooperation can identify high-risk containers and push back against what can seem like an incessant tide. Plus, UNODC's Bob van den Berghe explains how work in source countries can prevent illegal cargo ever getting on board a commercial vessel and strengthen relationships between law enforcement agencies at opposite sides of an ocean. Joining Joshua on the podcast are: • Joe Kramek, chief executive, World Shipping Council • Bob Van den Berghe, deputy head PCCP, UN Office on Drugs and Crime • Niels Vanlaer, harbour master at the port of Antwerp-Bruges • Robert Campbell, programme director, United for Wildlife

This lecture provides a comprehensive overview of the constitutional foundations of criminal procedure law, focusing on the Fourth Amendment. It explores the sources of criminal procedure, the significance of judicial interpretation, and the balance between law enforcement and individual rights. Key topics include the definitions of searches and seizures, warrant requirements, exceptions to these requirements, and the implications of modern technology on privacy rights. The lecture concludes with a discussion on the exclusionary rule and its impact on the justice system.TakeawaysThe Fourth Amendment establishes protections against unreasonable searches and seizures.Judicial decisions play a crucial role in interpreting constitutional provisions.The concept of reasonable expectation of privacy is central to Fourth Amendment analysis.Warrants must be issued by a neutral magistrate based on probable cause.Exceptions to the warrant requirement include searches incident to arrest and exigent circumstances.The exclusionary rule prevents illegally obtained evidence from being used in court.The good faith exception allows some leeway for law enforcement actions.Modern technology poses new challenges to Fourth Amendment protections.The open fields doctrine limits privacy rights in areas outside the home.Policy debates continue regarding the balance between law enforcement and individual rights.Criminal Procedure, Fourth Amendment, Searches, Seizures, Warrant Requirements, Exclusionary Rule, Privacy Rights, Law Enforcement, Constitutional Law, Judicial Interpretation

In this podcast, Margie A. Ream discusses her paper 'Seizures in childhood cerebral adrenoleukodystrophy'.   The paper is available here: https://doi.org/10.1111/dmcn.16321   Follow DMCN on Podbean for more: https://dmcn.podbean.com/ ___ Watch DMCN Podcasts on YouTube: https://bit.ly/2ONCYiC __ DMCN Journal: Developmental Medicine & Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families. DMCN Journal - https://onlinelibrary.wiley.com/journal/14698749 ___ Find us on Twitter! @mackeithpress - https://twitter.com/mackeithpress

What happens when your brain betrays you with seizures that arrive without warning and leave you depressed for days? Meet Landis, a writer and podcaster who developed epilepsy after brain tumor surgery at age 32. In this illuminating conversation, she breaks down the reality of living with seizures that arrive without warning, including the four-day depression cycle that follows each episode. From creating a post-seizure self-care system complete with personal reminders, to experiencing fascinating "auras" where her brain conjures fictional characters like "Mrs. Bit Binder," Landis shares it all with remarkable honesty and humor. She also discusses how epilepsy affected her dating life (including having a seizure during some hanky panky sexy times!), the service dog who detects her seizures before they happen, and how this condition has simultaneously limited her independence while deepening her appreciation for life's small moments. A powerful reminder of resilience in the face of chronic illness.You can watch this entire episode over on YouTube!Check out Landis' podcast "What The Ef"Follow Sickboy on Instagram, TikTok and Discord.

What happens when your brain betrays you with seizures that arrive without warning and leave you depressed for days? Meet Landis, a writer and podcaster who developed epilepsy after brain tumor surgery at age 32. In this illuminating conversation, she breaks down the reality of living with seizures that arrive without warning, including the four-day depression cycle that follows each episode. From creating a post-seizure self-care system complete with personal reminders, to experiencing fascinating "auras" where her brain conjures fictional characters like "Mrs. Bit Binder," Landis shares it all with remarkable honesty and humor. She also discusses how epilepsy affected her dating life (including having a seizure during some hanky panky sexy times!), the service dog who detects her seizures before they happen, and how this condition has simultaneously limited her independence while deepening her appreciation for life's small moments. A powerful reminder of resilience in the face of chronic illness.You can watch this entire episode over on YouTube!Check out Landis' podcast "What The Ef"Follow Sickboy on Instagram, TikTok and Discord.

Dr. Halley Alexander discusses the Neurology Today article, “The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com.  Show reference: The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting

In V.E. Shwab's bestselling novel, A Conjuring of Light, she wrote, "Kings need not raise their voices to be heard." But on this episode of Talk About It, Greg talks to a King who is being heard not by raising his voice, but by writing a book of his own! That book is called Be There When I Return, and it is out NOW everywhere books are sold. Michael King seemed to have everything going his way as a young bartender in 1980's Los Angeles until his friends began to notice a bizarre quirk in his behavior, but he is not aware of it happening. After the closest people in his life convince him to see a doctor, he is hit with the reality of an epilepsy diagnosis and drags through years of not being able to control his seizures. He ends up becoming a candidate for an experimental surgery, but his family doesn't know if he will remember them when he wakes up. We'll let Michael fill in the rest of this story, but you don't want to miss this episode!  The Talk About It podcast is excited to be sponsored in part by Neurelis. The Talk About It podcast is excited to also be sponsored in part by Seizures Are Signs — dedicated to educating families on the importance of early and specific diagnosis by providing an assessment to help get the conversation started, educational information, stories from families who have found a diagnosis, links to advocacy groups, and more. For more information, go to SeizuresAreSigns.com. Seizures are Signs is made available by Jazz Pharmaceuticals.

A teenager who collapsed in a park in Ashford has been diagnosed with rare heart disorder after previous seizures were blamed on ‘anxiety'. The 16-year-old survived the ordeal but she has been left brain damaged – her family say her illness should have been detected much sooner. Also in today's podcast, dogs will be kicked off many of Kent's most popular beaches from today to make way for visitors coming to the coast this summer.The rules, in place until September 30, could see any dog walker caught breaking the rules risking a £100 fine – we've been on the coast to get reaction. Free rape alarms are being offered to all residents in a village after multiple flashing incidents were reported.One perpetrator is said to have exposed themselves to terrified women on several occasions near Whitstable last year.A village pub is set to have its licence reviewed over alleged fire safety failings.Kent Fire and Rescue Service has made a formal request to Medway Council to review the licence of the boozer in High Halstow over inadequate fire safety assessments and warning systems.And a pregnant Orangutan at at Kent animal park has been trained to have ultrasound scans like a human. Awan is critically endangered and the imminent arrival at Wingham near Canterbury is being seen as significant for the conservation of the species.

Febrile seizures are common in the first 5 years of life, and many factors that increase the risk of such seizures occurring have been identified. Initial evaluation should determine whether features of a complex seizure are present, as well as identifying the source of fever. In this episode, Dr Roger Henderson provides an overview of febrile seizures in childhood and also looks at risk factors, referral criteria, treatment options and prognosis.Access episode show notes containing key references and take-home points at: https://gpnotebook.com/en-GB/podcasts/paediatrics/ep-154-febrile-seizuresDid you know? With GPnotebook Pro, you can earn CPD credits by tracking the podcast episodes you listen to. Learn more.

In this episode, the moms discuss the complex relationship between seizures and autism, sharing personal stories and insights. They explore how seizures can manifest in individuals with autism and discuss various coping strategies for families affected by these challenges. Listeners will better understand the neurological aspects at play and treatment options. The episode aims to foster awareness, encouraging open dialogue about the struggles and triumphs of those navigating this journey. We hope you listen and share it with others. Thank you for connecting with us!If you like our podcast, please share, review, and subscribe! You can find us at:⁠⁠⁠⁠⁠⁠⁠⁠Navigating Adult Autism on Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Navigatingadultautismpodcast on Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Navigatingadultautism.com⁠⁠⁠⁠⁠⁠⁠⁠You can also find Heather Woodring write about her son Zachary at⁠⁠⁠⁠⁠⁠⁠⁠Everyday Adventures with Zachary on Facebook

Toddlerhood comes with lots of surprises, and some can be a little scary.  Have you ever noticed your little one zoning out or holding their breath and that made you pause and question, “Is that normal?” You're not alone. Toddler spells can be alarming for parents, and it can be hard to tell the difference between a harmless toddler spell and a seizure.   In this episode, we're joined by two pediatric neurologists, Dr. Marissa Vawter-Lee and Dr. Barbara Hallinan, to break down toddler spells vs. seizures. We talk about common toddler spells—like breath-holding or staring spells— what they look like, and what to do in the moment. We also cover how to tell a spell from a seizure, including signs and symptoms of seizures and what you should and shouldn't do if your child is having a seizure. 

WE

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "Sleep and Seizures: Emerging Insights From AAN 2025," Nancy Foldvary-Schaefer, DO, director of the Sleep Disorders Center at Cleveland Clinic, reflected on key sleep-related topics presented at this year's AAN Annual Meeting. She highlighted the growing clinical interest in underrecognized conditions like idiopathic hypersomnia and narcolepsy, stressing the need for better awareness and earlier diagnosis. Foldvary-Schaefer also detailed the development of the Sleep by Cleveland Clinic mobile app, designed to improve screening for common sleep disorders with validated tools and real-time resources. Additionally, she discussed new findings on the prevalence of obstructive sleep apnea in adults with epilepsy, pointing to the importance of routine sleep screening in this population, regardless of seizure severity. Finally, she shared exploratory data on SSRI use and peri-ictal respiratory patterns in epilepsy, offering new perspectives on potential protective mechanisms tied to SUDEP risk. Looking for more neuromuscular discussion? Check out the NeurologyLive® Sleep disorders clinical focus page. Episode Breakdown: 1:00 – Key sleep topics discussed at AAN 2025 and the growing interest in hypersomnia 5:45 – Development and purpose of the SLEEP mobile app by Cleveland Clinic 10:35 – Findings on obstructive sleep apnea prevalence in adults with epilepsy 15:05 – Neurology News Minute 17:10 – The need for sleep disorder screening in epilepsy clinical trials 19:45 – Exploratory findings on SSRI use and respiratory patterns in patients with epilepsy The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Pre-Filled Syringe Administration for FcRn Modulator Efgartigimod FDA Approves CT-132 as First Digital Therapeutic for Preventive Treatment of Episodic Migraine FDA Expands Diazepam Nasal Spray Indication to Treat Ages 2 to 5 Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Finally. An episode that is less than 2 hours long. It helps that this week we're covering Seizures in Barren Praise by grind/crust band Trap Them. The album is only 10 tracks and 25 minutes total. Compared to the last few episodes this one just BREEZES by! It also helps that Seizures in Barren Praise by Trap Them happens to be one of my favorite albums of all time. Illegally downloading this album from some guy's blogspot page when I was 16 started a snowball effect that would alter how I listened to heavy music going forward which made this a bit of a nostalgia trip for me. We also do our best to parse through the loose plot that makes up the concept of not only this album but all of Trap Them's music up to this point. The vinyl I have here I believe is a second pressing, standard weight on ultra clear vinyl. It comes in a nice enough trifold jacket which shows off the album's full artwork done by Converge vocalist Jacob Bannon. The album sounds perfectly fine. Minimal surface noise but if we're being honest, any surface noise would get lost in the chaos of the album anyway. I picked this up a few years ago used from Pharmacy Records in Greenville which is, for my money, the best place in the upstate to find metal/punk/hardcore records. We're lucky enough to have a few decent record stores here in the upstate but if you're into heavy music at all, Pharmacy is the one you wanna go to. In the news corner this week we check in with our old pal Tim Lambesis and see what his old band members are saying about him. Hint: it's not good. We also check in with what's going on with Death Grips and Andy Morin to see what a new band member is saying about him. Hint: It's not good.Instagram - @MBFrecordspodAmanda's IG/TikTok/YouTube - @MothraLunaJason's Discogs - https://www.discogs.com/user/FrequencyShift/collection Theme music by SHADE08 x 80root on YouTube: https://www.youtube.com/watch?v=bewQPpTnfgg&list=PPSVHosted by Ausha. See ausha.co/privacy-policy for more information.

Prof. Jon Stone, Dr. Laura Strom, and Meagan Watson discuss functional seizures and healthcare costs related to the functional seizure program at the University of Colorado. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200393 

Prof. Jon Stone talks with Dr. Laura Strom and Meagan Watson about changes in total emergency department and inpatient visits and costs before and after referral to a specialized, comprehensive functional seizure treatment clinic. Read the related article with Neurology® Clinical Practice. Disclosures can be found at Neurology.org.   

Diagnosing and differentiating among the many possible localizations and causes of vision loss is an essential skill for neurologists. The approach to vision loss should include a history and examination geared toward localization, followed by a differential diagnosis based on the likely location of the pathophysiologic process.  In this episode, Aaron Berkowitz, MD, PhD, FAAN speaks with Nancy J. Newman, MD, FAAN, author of the article “Approach to Vision Loss” in the Continuum® April 2025 Neuro-ophthalmology issue.  Dr. Berkowitz is a Continuum® Audio interviewer and a professor of neurology at the University of California San Francisco in the Department of Neurology and a neurohospitalist, general neurologist, and clinician educator at the San Francisco VA Medical Center at the San Francisco General Hospital in San Francisco, California.  Dr. Newman is a professor of ophthalmology and neurology at the Emory University School of Medicine in Atlanta, Georgia.  Additional Resources Read the article: Approach to Vision Loss Subscribe to Continuum®: shop.lww.com/Continuum  Earn CME (available only to AAN members): continpub.com/AudioCME  Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com  Social Media facebook.com/continuumcme  @ContinuumAAN  Host: @AaronLBerkowitz  Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Berkowitz: This is Dr Aaron Berkowitz, and today I'm interviewing Dr Nancy Newman about her article on the approach to visual loss, which she wrote with Dr Valerie Biousse. This article appears in the April 2025 Continuum issue on neuro-ophthalmology. Welcome to the podcast, Dr Newman. I know you need no introduction, but if you wouldn't mind introducing yourself to our listeners. Dr Newman: Sure. My name's Nancy Newman. I am a neurologist and neuro-ophthalmologist, professor of ophthalmology and neurology at the Emory University School of Medicine in Atlanta, Georgia. Dr Berkowitz: You and your colleague Dr Biousse have written a comprehensive and practical article on the approach to visual loss here. It's fantastic to have this article by two of the world's leading experts and best-known teachers in neuro-ophthalmology. And so, readers of this article will find extremely helpful flow charts, tables and very nuanced clinical discussion about how to make a bedside diagnosis of the cause of visual loss based on the history exam and ancillary testing. We'll talk today about that important topic, and excited to learn from you and for our listeners to learn from you. To begin, let's start broad. Let's say you have a patient presenting with visual loss. What's your framework for the approach to this common chief concern that has such a broad differential diagnosis of localizations and of causes? Where do you start when you hear of visual loss? How do you think about this chief concern? Dr Newman: Well, it's very fun because this is the heart of being a neurologist, isn't it? Nowhere in the nervous system is localization as important as the complaint of vision loss. And so, the key, as any neurologist knows, is to first of all figure out where the problem is. And then you can figure out what it is based on the where, because that will limit the number of possibilities. So, the visual system is quite beautiful in that regard because you really can exquisitely localize based on figuring out where things are. And that starts with the history and then goes to the exam, in particular the first localization. So, you can whittle it down to the more power-for-your-buck question is, is the vision lost in one eye or in two eyes? Because if the vision loss clearly, whether it's transient or persistent, is in only one eye, then you only have to think about the eyeball and the optic nerve on that side. So, think about that. Why would you ever get a brain MRI? I know I'm jumping ahead here, but this is the importance of localization. Because what you really want to know, once you know for sure it's in one eye, is, is it an eyeball problem---which could be anything from the cornea, the lens, the vitreous, the retina---or is it an optic nerve problem? The only caveat is that every once in a while, although we trust our patients, a patient may insist that a homonymous hemianopia, especially when it's transient, is only in the eye with the temporal defect. So that's the only caveat. But if it's in only one eye, it has to be in that side eyeball or optic nerve. And if it's in two eyes, it's either in both eyeballs or optic nerves, or it's chiasmal or retrochiasmal. So that's the initial approach and everything about the history should first be guided by that. Then you can move on to the more nuanced questions that help you with the whats. Once you have your where, you can then figure out what the whats are that fit that particular where. Dr Berkowitz: Fantastic. And your article with Dr Biousse has this very helpful framework, which you alluded to there, that first we figure out, is it monocular or binocular? And we figure out if it's a transient or fixed or permanent deficit. So, you have transient monocular, transient binocular, fixed monocular, fixed binocular. And I encourage our listeners to seek out this article where you have a table for each of those, a flow chart for each of those, that are definitely things people want to have printed out and at their desk or on their phone to use at the bedside. Very helpful. So, we won't be able to go through all of those different clinical presentations in this interview, but let's focus on monocular visual loss. As you just mentioned, this can be an eye problem or an optic nerve problem. So, this could be an ophthalmologic problem or a neurologic problem, right? And sometimes this can be hard to distinguish. So, you mentioned the importance of the history. When you hear a monocular visual loss- and with the caveat, I said you're convinced that this is a monocular visual problem and not a visual field defect that may appear. So, the patient has a monocular deficit, how do you approach the history at trying to get at whether this is an eye problem or an optic nerve problem and what the cause may be? Dr Newman: Absolutely. So, the history at that point tends not to be as helpful as the examination. My mentor used to say if you haven't figured out the answer to the problem after your history, you're in trouble, because that 90% of it is history and 10% is the exam. In the visual system, the exam actually may have even more importance than anywhere else in the neurologic examination. And we need as neurologists to not have too much hubris in this. Because there's a whole specialty on the eyeball. And the ophthalmologists, although a lot of their training is surgical training that that we don't need to have, they also have a lot of expertise in recognizing when it's not a neurologic problem, when it's not an optic neuropathy. And they have all sorts of toys and equipment that can very much help them with that. And as neurologists, we tend not to be as versed in what those toys are and how to use them. So, we have to do what we can do. Your directive thalmoscope, I wouldn't throw it in the garbage, because it's actually helpful to look at the eyeball itself, not just the back of the eye, the optic nerve and retina. And we'll come back to that, but we have in our armamentarium things we can do as neurologists without having an eye doctor's office. These include things like visual acuity and color vision, confrontation, visual fields. Although again, you have to be very humble. Sometimes you're lucky; 30% of the time it's going to show you a defect. It has to be pretty big to pick it up on confrontation fields. And then as we say, looking at the fundus. And you probably know that myself and Dr Biousse have been on somewhat of a crusade to allow the emperor's new clothes to be recognized, which is- most neurologists aren't very comfortable using the direct ophthalmoscope and aren't so comfortable, even if they can use it, seeing what they need to see. It's hard. It's really, really hard. And it's particularly hard without pupillary dilation. And technology has allowed us now with non-mydriatic cameras, cameras that are incredible, even through a small pupil can take magnificent pictures of the back of the eye. And who wouldn't rather have that? And as their cost and availability- the cost goes down and their availability goes up. These cameras should be part of every neurology office and every emergency department. And this isn't futuristic. This is happening already and will continue to happen. But over the next five years or so… well, we're transitioning into that. I think knowing what you can do with the direct ophthalmoscope is important. First of all, if you dial in plus lenses, you can't be an ophthalmologist, but you can see media opacities. If you can't see into the back of the eye, that may be the reason the patient can't see out. And then just seeing if someone has central vision loss in one eye, it's got to be localized either to the media in the axis of vision; or it's in the macula, the very center of the retina; or it's in the optic nerve. So, if you get good at looking at the optic nerve and then try to curb your excitement when you saw it and actually move a little temporally and take a look at the macula, you're looking at the two areas. Again, a lot of ophthalmologists these days don't do much looking with the naked eye. They actually do photography, and they do what's called OCT, optical coherence tomography, which especially for maculopathies, problems in the macula are showing us the pathology so beautifully, things that used to be considered subtle like central serous retinopathy and other macula. So, I think having a real healthy respect for what an eye care provider can do for you to help screen away the ophthalmic causes, it's very, very important to have a patient complaining of central vision loss, even if they have a diagnosis like multiple sclerosis, you expect that they might have an optic neuritis… they can have retinal detachments and other things also. And so, I think every one of these patients should be seen by an eye care provider as well. Dr Berkowitz: Thank you for that overview. And I feel certainly as guilty as charged here as one of many neurologists, I imagine, who wish we were much better and more comfortable with fundoscopy and being confident on what we see. But as you said, it's hard with the direct ophthalmoscope and a non-dilated exam. And it's great that, as you said, these fundus photography techniques and tools are becoming more widely available so that we can get a good look at the fundus. And then we're going to have to learn a lot more about how to interpret those images, right? If we haven't been so confident in our ability to see the fundus and analyze some of the subtle abnormalities that you and your colleagues and our ophthalmology colleagues are more familiar with. So, I appreciate you acknowledging that. And I'm glad to hear that coming down the pipeline, there are going to be some tools to help us there. So, you mentioned some of the things you do at the bedside to try to distinguish between eye and optic nerve. Could you go into those in a little bit more detail here? How do you check the visual fields? For example, some people count fingers, some people wiggle fingers, see when the patient can see. How should we be checking visual fields? And what are some of the other bedside tasks you use to decide this is probably going to end up being in the optic nerve or this seems more like an eye? Dr Newman: Of course. Again, central visual acuity is very important. If somebody is older than fifty, they clearly will need some form of reading glasses. So, keeping a set of plus three glasses from cheapo drugstore in your pocket is very helpful. Have them put on their glasses and have them read an ear card. It's one of the few things you can actually measure and examine. And so that's important. The strongest reflex in the body and I can have it duke it out with the peripheral neurologists if they want to, it's not the knee jerk, it's looking for a relative afferent pupillary defect. Extremely important for neurologists to feel comfortable with that. Remember, you cut an optic nerve, you're not going to have anisocoria. It's not going to cause a big pupil. The pupils are always equal because this is not an efferent problem, it's an afferent problem, an input problem. So basically, if the eye has been injured in the optic nerve and it can't get that information about light back into the brain, well, the endoresfol nuclei, both of them are going to reset at a bigger size. And then when you swing over and shine that light in the good optic nerve, the good eye, then the brain gets all this light and both endoresfol nuclei equally set those pupils back at a smaller size. So that's the test for the relative afferent pupillary defect. When you swing back and forth. Of course, when the light falls on the eye, that's not transmitting light as well to the brain, you're going to see the pupil dilate up. But it's not that that pupil is dilating alone. They both are getting bigger. It's an extremely powerful reflex for a unilateral or asymmetric bilateral optic neuropathy. But what you have to remember, extremely important, is, where does our optic nerve come from? Well, it comes from the retinal ganglion cells. It's the axons of the retinal ganglion cells, which is in the inner retina. And therefore inner retinal disorders such as central retinal artery occlusion, ophthalmic artery occlusion, branch retinal artery occlusion, they will also give a relative afferent pupillary defect because you're affecting the source. And this is extremely important. A retinal detachment will give a relative afferent pupillary defect. So, you can't just assume that it's optic nerve. Luckily for us, those things that also give a relative afferent pupillary defect from a retinal problem cause really bad-looking retinal disease. And you should be able to see it with your direct ophthalmoscope. And if you can't, you definitely will be able to see it with a picture, a photograph, or having an ophthalmologist or optometrist take a look for you. That's really the bedside. You mentioned confrontation visual fields. I still do them, but I am very, very aware that they are not very sensitive. And I have an extremely low threshold to- again, I have something in my office. But if I were a general neurologist, to partner with an eye care specialist who has an automated visual field perimeter in their office because it is much more likely to pick up a deficit. Confrontation fields. Just remember, one eye at a time. Never two eyes at the same time. They overlap with each other. You're going to miss something if you do two eyes open, so one eye at a time. You check their field against your field, so you better be sure your field in that eye is normal. You probably ought to have an automated perimetry test yourself at some point during your career if you're doing that. And remember that the central thirty degrees is subserved by 90% of our fibers neurologically, so really just testing in the four quadrants around fixation within the central 30% is sufficient. You can present fingers, you don't have to wiggle in the periphery unless you want to pick up a retinal detachment. Dr Berkowitz: You mentioned perimetry. You've also mentioned ocular coherence tomography, OCT, other tests. Sometimes we think about it in these cases, is MRI one of the orbits? When do you decide to pursue one or more of those tests based on your history and exam? Dr Newman: So again, it sort of depends on what's available to you, right? Most neurologists don't have a perimeter and don't have an OCT machine. I think if you're worried that you have an optic neuropathy, since we're just speaking about monocular vision loss at this point, again, these are tests that you should get at an office of an eye care specialist if you can. OCT is very helpful specifically in investigating for a macular cause of central vision loss as opposed to an optic nerve cause. It's very, very good at picking up macular problems that would be bad enough to cause a vision problem. In addition, it can give you a look at the thickness of the axons that are about to become the optic nerve. We call it the peripapillary retinal nerve fiber layer. And it actually can look at the thickness of the layer of the retinal ganglion cells without any axons on them in that central area because the axons, the nerve fiber layer, bends away from central vision. So, we can see the best we can see. And remember these are anatomical measurements. So, they will lag, for the ganglion cell layer, three to four weeks behind an injury, and for the retinal nerve fiber, layer usually about six weeks behind an entry. Whereas the functional measurements, such as visual acuity, color vision, visual fields, will be immediate on an injury. So, it's that combination of function and anatomy examination that makes you all-powerful. You're very much helped by the two together and understanding where one will be more helpful than the other. Dr Berkowitz: Let's say we've gotten to the optic nerve as our localization. Many people jump to the assumption it's the optic nerve, it's optic neuritis, because maybe that's the most common diagnosis we learn in medical school. And of course, we have to sometimes, when we're teaching our students or trainees,  say, well, actually, not all optic nerve disease, optic neuritis, we have to remember there's a broader bucket of optic neuropathy. And I remember, probably I didn't hear that term until residency and thought, oh, that's right. I learned optic neuritis. Didn't really learn any of the other causes of optic nerve pathology in medical school. And so, you sort of assume that's the only one. And so you realize, no, optic neuropathy has a differential diagnosis beyond optic neuritis. Neuritis is a common cause. So how do you think about the “what” once you've localized to the optic nerve, how do you think about that? Figure out what the cause of the optic neuropathy is? Dr Newman: Absolutely. And we've been trying to convince neuro-radiologists when they see evidence of optic nerve T2 hyperintensity, that just means damage to the optic nerve from any cause. It's just old damage, and they should not put in their read consistent with optic neuritis. But that's a pet peeve. Anyway, yes, the piece of tissue called the optic nerve can be affected by any category of pathophysiology of disease. And I always suggest that you run your categories in your head so you don't leave one out. Some are going to be more common to be bilateral involvement like toxic or metabolic causes. Others will be more likely unilateral. And so, you just run those guys. So, in my mind, my categories always are compressive-slash-infiltrative, which can be neoplastic or non-neoplastic. For example, an ophthalmic artery aneurysm pressing on an optic nerve, or a thyroid, an enlarged thyroid eye muscle pressing on the optic nerve. So, I have compressive infiltrative, which could be neoplastic or not neoplastic. I have inflammatory, which can be infectious. Some of the ones that can involve the optic nerve are syphilis, cat scratch disease. Or noninfectious, and these are usually your autoimmune such as idiopathic optic neuritis associated with multiple sclerosis, or MOG, or NMO, or even sarcoidosis and inflammation. Next category for me would be vascular, and you can have arterial versus venous in the optic nerve, probably all arterial if we're talking about causes of optic neuropathy. Or you could have arteritic versus nonarteritic with the vascular, the arteritic usually being giant cell arteritis. And the way the optic nerve circulation is, you can have an anterior ischemic optic neuropathy or a posterior ischemic optic neuropathy defined by the presence of disc edema suggesting it's anterior, the front of the optic nerve, or not, suggesting that it's retrobulbar or posterior optic nerve. So what category am I- we mentioned toxic, metabolic nutritional. And there are many causes in those categories of optic neuropathy, usually bilateral. You can have degenerative or inherited. And there are causes of inherited optic neuropathies such as Leber hereditary optic neuropathy and dominant optic atrophy. And then there's a group I call the mechanical optic neuropathies. The obvious one is traumatic, and that can happen in any piece of tissue. And then the other two relate to the particular anatomy of the eyeball and the optic nerve, and the fact that the optic nerve is a card-carrying member of the central nervous system. So, it's not really a nerve by the way, it's a tract. Think about it. Anyway, white matter tract. It is covered by the same fluid and meninges that the rest of the brain. So, what mechanically can happen? Well, you could have an elevated intraocular pressure where that nerve inserts. That's called glaucoma, and that would affect the front of the optic nerve. Or you can have elevated intracranial pressure. And if that's transmitted along the optic nerve, it can make the front of the optic nerve swell. And we call that specifically papilledema, optic disk edema due specifically to raised intracranial pressure. We actually even can have low intraocular pressure cause something called hypotony, and that can actually even give an optic neuropathy the swelling of the optic nerve. So, these are the mechanical. And if you were to just take that list and use it for any piece of tissue anywhere, like the heart or the kidney, you can come up with your own mechanical categories for those, like pericarditis or something like that. And then all those other categories would fit. But of course, the specific causes within that pathophysiology are going to be different based on the piece of tissue that you have. In this case, the optic nerve. Dr Berkowitz: In our final moments here, we've talked a lot about the approach to monocular visual loss. I think most neurologists, once we find a visual field defect, we breathe a sigh of relief that we know we're in our home territory here, somewhere in the visual task base that we've studied very well. I'm not trying to distinguish ocular causes amongst themselves or ocular from optic nerve, which can be very challenging at the bedside. But one topic you cover in your article, which I realized I don't really have a great approach to, is transient binocular visual loss. Briefly here, since we're running out of time, what's your approach to transient binocular visual loss?  Dr Newman: We assume with transient binocular vision loss that we are not dealing with a different experience in each eye, because if you have a different experience in each eye, then you're dealing with bilateral eyeball or optic nerve. But if you're having the same experience in the two eyes, it's equal in the two eyes, then you're located. You're located, usually, retro chiasmally, or even chiasm if you have pituitary apoplexy or something. So, all of these things require imaging, and I want to take one minute to talk about that. If you are sure that you have monocular vision loss, please don't get a brain MRI without contrast. It's really useless. Get a orbital MRI with contrast and fat suppression techniques if you really want to look at the optic nerve. Now, let's say you you're convinced that this is chiasmal or retrochiasmal. Well then, we all know we want to get a brain MRI---again, with and without contrast---to look specifically where we could see something. And so, if it's persistent and you have a homonymous hemianopia, it's easy, you know where to look. Be careful though, optic track can fool you. It's such a small little piece, you may miss it on the MRI, especially in someone with MS. So really look hard. There's very few things that are homonymous hemianopias MRI negative. It may just be that you didn't look carefully enough. And as far as the transient binocular vision loss, again, remember, even if it's persistent, it has to be equal vision in the two eyes. If there's inequality, then you have a superimposed anterior visual pathway problem, meaning in front of the chiasm on the side that's worse. The most common cause of transient binocular vision loss would be a form of migraine. The visual aura of migraine usually is a positive phenomenon, but sometimes you can have a homonymous hemianopic persistent defect that then ebbs and flows and goes away. Usually there's buildup, lasts maybe fifteen minutes and then it goes away, not always followed by a headache. Other things to think of would be transient ischemic attack in the vertebra Basler system, either a homonymous hemianopia or cerebral blindness, what we call cortical blindness. It can be any degree of vision loss, complete or any degree, as long as the two eyes are equal. That should last only minutes. It should be maximum at onset. There should be no buildup the way migraine has it. And it should be gone within less than ten minutes, typically. After fifteen, that's really pushing it. And then you could have seizures. Seizures can actually be the aura of a seizure, the actual ictal phenomenon of a seizure, or a postictal, almost like a todd's paralysis after a seizure. These events are typically bright colors and flashing, and they last usually seconds or just a couple of minutes at most. So, you can probably differentiate them. And then there are the more- less common but more interesting things like hyperglycemia, non-ketonic hyperglycemia can give you transient vision loss from cerebral origin, and other less common things like that. Dr Berkowitz: Fantastic. Although we've talked about many pearls of clinical wisdom here with you today, Dr Newman, this is only a fraction of what we can find in your article with Dr Biousse. We focused here on monocular visual loss and a little bit at the end here on binocular visual loss, transient binocular visual loss. But thank you very much for your article, and thank you very much for taking the time to speak with us today. Again, today I've been interviewing Dr Nancy Newman about her article with Dr Valerie Biousse on the approach to visual loss, which appears in the most recent issue of Continuum on neuro-ophthalmology. Be sure to check out Continuum audio episodes from this and other issues. Thank you so much to our listeners for joining us today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Contributor: Taylor Lynch, MD Educational Pearls: Pediatric febrile seizures are defined as seizures that occur between the ages of six months to five years in the presence of a fever greater than or equal to 38.0 ºC (100.4 ºF). It is the most common pediatric convulsive disorder, with an incidence between 2-5% What are the types of seizures? Simple: Tonic-clonic seizure, duration

"FREEDOM DENIED" pt 2 with guest Diane Bukowski , Attorney Brian Brown & My Detroit Lawyer, is the continuation of Freedom Denied conversation. We dive deeper into the fight against wrongful convictions and systemic injustice. Investigative journalist Diane Bukowski and seasoned defense Attorney Brian Brown who represented Michael Jackson-Bolanos, will join the conversation to expose legal failures, prosecutorial misconduct, and the human cost of a broken justice system. My Detroit Lawyer returns to bring raw insights, expert analysis, and firsthand accounts from the frontlines of justice.GUEST....-Diane Bukowski: Editor, Publisher and investigative journalist of Voice of Detroit https://voiceofdetroit.net-Attorney Brian Brown: Attorney at BLegalPLLC. Criminal Defense, Illegal Searches and Seizures, & Concealed Weapons Charges https://attorneybrianbrown.com-My Detroit Lawyer: Criminal Defense in the Metro Detroit, with a “FOCUS ON ALWAYS PUTTING OUR CLIENT FIRST” www.mydetroitlawyer.comTurning A Moment Ino A Moment Team:-Jay Love Host: Founder and Creator of Turning A Moment Into A Movement, The Justice for Gerard Movement, to learn more about The Justice for Gerard Movement go to: ⁠www.change.org/Justice4Gerard⁠Executive Board member of Michigan Coalition of Human Rights, G100 Prison Reforms & Reintegration Global Advisory Council Member-Rev. Tia Littlejohn: Behavioral Therapist, Founder of the Choice Zone, G100 Global Chair G100 Prison Reforms & Reintegration, Co-Chair & Executive Board member of Michigan Coalition of Human Rights, Author, www.thechoicezone.com-Trische' Duckworth: Executive Director/Founder of Survivors Speak, Founder/ Lead Consultant of Value Black Lives, Social Worker, Justice Advocate, Board member of Michigan Coalition of Human Rights, https://www.survivorsspeak.info-Leslie McGraw: Poet, Writer, and Social Media and Voting Rights Activist Owner, Les Go Social Media Marketing & Training (Les Go Social MM&T) Founder, Elbert Williams Voting Corner, Board Member and VOTE Caucus Leader, Interfaith Council for Peace & Justice (ICPJ) Communications Lead, Protectors of Equality in Government (PEG), Member, Allies of Mental Health of Washtenaw County www.elbertwilliamsvotingcorner.com-Alexanderia Hudges: Mental health and human rights Activist, Master's degree student at Wayne State University, and Board member with the Michigan Coalition of Human Rights https://linktr.ee/AlexandriaJHughes***Turning A Moment Into A Movement Podcast MISSION:To bring awareness, organize, and create content that will be a resource that will aide families, communities, and those seeking Justice for WRONGFUL CONVICTIONS and Injustice. ...and advocating for Justice & Exoneration for GERARD HAYCRAFT. change.org/Justice4GerardI do not own the rights to the music. No copyright infringement intended. Musical Content Copyright Disclaimer (Fair Use) under section 107 Copyright Act 1976, allowance is made for "fair use" for purposes. https://linktr.ee/turningamomentintoamovement

A deputy sheriff in Alabama has admitted guilt in connection with the mistreatment of a vulnerable inmate who later died as a result of his treatment while in custody.See omnystudio.com/listener for privacy information.

PJ talks to Opinion Line Producer Paul Byrne who found figures for Cork City Council's horse welfare activities and to Kelly Mellerick of My Lovely Horse Rescue Hosted on Acast. See acast.com/privacy for more information.

The Hidden Dangers of Modern Marijuana: A Deep DiveIn this episode of Clearing the Haze, host Chuck Marty explores the alarming new findings on the health risks associated with modern marijuana use, particularly among individuals under 50. Emerging research indicates a significantly higher risk of heart attacks, strokes, heart failure, and cardiovascular death among cannabis users. The episode also delves into marijuana's impact on mental health, highlighting its potential connection to schizophrenia and psychosis. Real-life stories and scientific studies underscore the serious, often overlooked, dangers of marijuana, making a strong case for increased awareness and education on this widely accepted substance.00:00 Introduction to Modern Marijuana Risks00:58 Marijuana and Cardiovascular Health02:47 Real-Life Impact Story: Jake's Heart Attack03:30 Marijuana and Mental Health05:13 Seizures and Overdoses: The Unspoken Risks06:20 Final Thoughts and Precautions06:55 Conclusion and ReferencesReferencesDenver7 News. "Marijuana users under age 50 are six times more likely to have a heart attack, study finds."National Institute on Drug Abuse. "Young men at highest risk of schizophrenia linked with cannabis use disorder."Healthline. "Cannabis Users Under 50 Are 6 Times More Likely to Have a Heart Attack." 

This major social media influencer is talking about it in a HUGE WAY! Jamie Simpson is not afraid of showing it all when it comes to her epilepsy -- and she is encouraging all of us to be bold when sharing our story. From dating, to having seizures in public places and showing us, to her incredible service dog Echo, Jamie lays it all on the line to help others understand the world of epilepsy, from the point of view of someone who has the condition. All in this episode of TALK ABOUT IT with Greg Grunberg. The Talk About It podcast is excited to be sponsored in part by Neurelis. The Talk About It podcast is excited to also be sponsored in part by Seizures Are Signs — dedicated to educating families on the importance of early and specific diagnosis by providing an assessment to help get the conversation started, educational information, stories from families who have found a diagnosis, links to advocacy groups, and more. For more information, go to SeizuresAreSigns.com. Seizures are Signs is made available by Jazz Pharmaceuticals.

In this episode of The Mind Change Podcast emotional drivers series, Heather McKean unpacks the subconscious patterns that may be driving epilepsy, offering a new perspective on healing. From childhood trauma to internalized pressure, discover the hidden emotional connections behind seizures and how understanding them could be the key to transformation. Don't miss this eye-opening discussion on mind-body healing!

“Unqualified” to Unstoppable: Cath's Journey Through Skateboarding, Mental Health & Purpose This episode is for anyone who's ever thought, “I'm not ready” or “That space isn't for me.”Cath didn't just break into the world of skateboarding—she smashed down the doors with two months on a board, a load of guts, and just the right amount of delusional confidence (her words, not ours).From applying for a job she didn't feel qualified for, to building a career empowering young girls through skateboarding, Cath's story is a bold reminder that passion and purpose beat perfection every time.We talk mental health, ADHD, epilepsy, self-belief, and how skateboarding has become a tool for healing, growth, and community. There's grit, there's humour, and there's a whole lot of heart.Trust me—whether you've never stepped on a board in your life or you're just looking for a reminder to back yourself—you'll feel this one.

In this week's podcast, Neurology Today's editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new guideline on migraine prevention from ACP, and an updated position statement from the AAN on seizures, driver licensures, and medical reporting.

In this week's episode of the Coin Stories News Block powered by Gemini, we cover these major headlines related to Bitcoin and global finance: Gold Breaks $3,000 as Global Uncertainty Surges Bitcoin Securities Market is Booming EU Planning to Seize Citizens' Savings Trader Predicts $84K Bitcoin to the Dollar—Now He's Calling for $444K ---- Invest as you spend with the Gemini Credit Card. Sign up today to earn a $200 intro Bitcoin bonus. The Gemini Credit Card is issued by WebBank: www.gemini.com/natalie ---- Join my mailing list and subscribe to our free newsletter: thenewsblock.substack.com  ---- References mentioned in the episode:  Economic Policy Uncertainty Index Spikes  Gold Surpasses $3,000/oz for First Time in History Gold is Best-performing Asset Class of the 21st Century BlackRock's Mitchnick's Thoughts on Recent BTC Price Action BlackRock's Report on Bitcoin as a Hedge Against Uncertainty Tuur Demeester's Chart on Bitcoin-to-Gold Ratio MGX Invests in Binance in Landmark Investment  Spain's Second-Largest Bank to Offer Bitcoin Strategy Announces $21 Billion Preferred Stock Offering REX Launches New Bitcoin-backed Convertible Debt ETF BMAX Gives Retail Investors Exposure to Bitcoin Converts Bitwise Launches Bitcoin Corporations ETF  Bitwise Launches ETF of Firms Holding >1,000 BTC Rumble Buys Another $17 million Bitcoin  EU to “Mobilize” €10T of Citizens' Savings  EU Announces Savings and Investment Union  EU Speech on Savings and Investment Union EU President von der Leyen's Press Remarks Josh Mandell's March 14th $84K Price Prediction  Bitcoin Closes at Exactly $84,000 on March 14th A Thread Explaining Josh Mandell's Price Prediction ---- Bitcoin 2025 is heading to Las Vegas May 27-29th! Join me for my 4th Annual Women of Bitcoin Brunch! Get 10% off Early Bird passes using the code HODL: https://tickets.b.tc/affiliate/hodl/event/bitcoin-2025   ---- This podcast is for educational purposes and should not be construed as official investment advice. ---- VALUE FOR VALUE — SUPPORT NATALIE'S SHOWS Strike ID https://strike.me/coinstoriesnat/ Cash App $CoinStories #money #Bitcoin #investing

Ahhh, it's that time of the year! Pitchers and catchers report, spring training is underway, we buy hotdogs and beer from a guy yelling up the stairs, it's just perfection! Nobody loves the feeling of the start of baseball season more than Greg, maybe with the exception of this episode's guest. Greg sits down in studio with Joey Hanley, a former college player who has now devoted his life to coaching and training young-and-promising baseball players to achieve their dreams of playing in college and beyond. This success didn't come without struggle, however, but luckily Joey had the right mindset to take it head on. Joey was diagnosed with epilepsy after he hit his head in the bathroom following a seizure when he was younger, and he battled through this diagnosis to achieve success on and off the diamond. He isn't going to let epilepsy slow him down from anything that he wants to do, and neither should you. Don't miss this episode! The Talk About It podcast is excited to be sponsored in part by Neurelis. The Talk About It podcast is excited to sponsored in part by Seizures Are Signs — dedicated to educating families on the importance of early and specific diagnosis by providing an assessment to help get the conversation started, educational information, stories from families who have found a diagnosis, links to advocacy groups, and more. For more information, go to SeizuresAreSigns.com. Seizures are Signs is made available by Jazz Pharmaceuticals.

Pediatrician Dr. Paul Bunch consults Dr. Barbara Hallinan and Dr. Marrisa Vawter-Lee from the Cincinnati Children's Division of Neurology on infant/toddler spells and seizures.  Episode recorded on February 19, 2025. CME & MOC Part 2 We are proud to offer CME and MOC Part 2 from Cincinnati Children's.  Credit is free and registration is required.  Please click here to claim CME credit via the post-test under "Launch Activity." Resources discussed in this episode: Community Practice Support Tool PCP Support Tools   Financial Disclosure:  The following relevant financial relationships have been disclosed: None All relevant financial relationships listed have been mitigated. Remaining persons in control of content have no relevant financial relationships.. To Claim Credit: Click "Launch Activity." Click "Launch Website" to access and listen to the podcast. After listening to the entire podcast, click "Post Test" and complete. Accreditation In support of improving patient care, Cincinnati Children's Hospital Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Specific accreditation information will be provided for each activity. Physicians: Cincinnati Children's designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing: This activity is approved for a maximum 0.5 continuing nursing education (CNE) contact hours. ABP MOCpt 2: Completion of this CME activity, which includes learner assessment and feedback, enables the learner to earn up to 0.5 points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. Cincinnati Children's submits MOC/CC credit for board diplomates. Credits AMA PRA Category 1 Credits™ (0.50 hours), ABP MOC Part 2 (0.50 hours), CME - Non-Physician (Attendance) (0.50 hours), Nursing CE (0.50 hours)

What to do if your dog is having a seizure - like Sam's sweet boy, Gus. #family #dogs #petsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Connect with the Hosts! Dr. Charlie Website Instagram Membership  Nurse Lauren Website Instagram Email List Amazon StoreFront Membership E-Book on Natural Remedies Check out our website: https://www.redpillyourhealthcast.com/ Welcome back to Red Pill Your Healthcast! Dr. Charlie Fagenholz and Nurse Lauren Johnson are tackling listener-submitted health questions. This week, we dive into: Endometriosis – How diet, lifestyle, and natural remedies can help manage symptoms. Febrile Seizures – Natural approaches to support the body during a fever response. Whooping Cough – The Vitamin C protocol and herbal support for lung health. Gallbladder Removal – How the body responds  and key strategies to support digestion. Clean Living in a Community – How to stay true to a holistic lifestyle while navigating social settings    Supplements + Products Mentioned: All VerVita Supplements Mentioned: Shop All Supreme Supplements Mentioned: Shop Lauren's Fullscript: https://us.fullscript.com/welcome/naturalnursemomma   Dr. Charlie's Fullscript: https://us.fullscript.com/welcome/cfagenholz   —------------------------------ Advanced Endometriomas Artichoke – Shop here: Supports liver and digestion Chaste Tree Supreme – Balances hormones Reducing inflammation through diet and lifestyle Resveratrol from Apex (Shop in Fullscript) – Antioxidant support Japanese Knotweed Supreme – Anti-inflammatory properties Red Infrared Light: Shop Here Emotional Trauma & Healing: Watch Dr. Charlie's Video in Membership EFT Tapping: Learn More Here Find an NET Provider: More Info Castor Oil Packs – Supports detox & circulation SRT Light Therapy: Supports nervous system regulation. Shop Here (Use code DRCHARLIE50 for $50 off) Febrile Seizures Peppermint Oil Epsom Salt Baths – Shop Amazon Homeopathy (Bella Donna) – Shop Amazon The Wet Sock Method: Read This Blog Black Walnut Supreme – Supports microbial balance Scutellaria Supreme – Herbal immune support Acerola Supreme – High in vitamin C VerVita Immune Armor – Immune system support VerVita Matrix Synergy – Cellular health VerVita Elite Harmony Oil – Balances body systems Calcium Lactate by Standard Process: Shop in Fullscript Whooping Cough Vitamin C Protocol: Dr. Suzanne's Guide Astragalus Supreme – Supports lung health Usnea Supreme – Herbal immune support Scutellaria Supreme – Supports respiratory health Takesumi Supreme – Detox support VerVita Elite Harmony – Body balance VerVita Immune Armor  Watch the Deep Dive Vaccine Video in Dr. Charlie's Membership Just the Inserts Informations Here: https://justtheinserts.com/ Our Podcast on Vaccines The Elephant in the Room - Part One - Listen The Elephant in the Room - Part Two - Listen The Elephant in the Room - Part Three - Listen Bringing Food to Family Parties Favorite Snacks (PaleoValley use code DRCHARLIE for 15% off) Gallbladder Removal Watch the Gallbladder Video in Dr. Charlie's Membership Digestive Enzymes (Shop in Fullscript)  Oxfile – Aids liver and bile function Artichoke – Shop here Castor Oil Packs – Promotes circulation & detox

Seizures, Spouses & SHOCK! Absolute Chaos With Revenge Of The Cis | Friends With Davey Jackson!   Follow here: https://www.youtube.com/watch?v=nSW0-4KNB-A  

Seizures, Spouses & SHOCK! Absolute Chaos With Revenge Of The Cis | Friends With Davey Jackson!   Follow here: https://www.youtube.com/watch?v=nSW0-4KNB-A  

Emergency treatment may be necessary after a person's first seizure or at the onset of abnormal acute repetitive (cluster) seizures; it is required for status epilepticus. Treatment for these emergencies is dictated by myriad clinical factors and informed by published guidance as well as emerging research.   In this episode, Lyell K. Jones, MD, FAAN, speaks with David G. Vossler, MD, FAAN, FACNS, FAES, author of the article “First Seizures, Acute Repetitive Seizures, and Status Epilepticus,” in the Continuum® February 2025 Epilepsy issue. Dr. Jones is the editor-in-chief of Continuum: Lifelong Learning in Neurology® and is a professor of neurology at Mayo Clinic in Rochester, Minnesota. Dr. Vossler a clinical professor of neurology at the University of Washington School of Medicine in Seattle, Washington. Additional Resources Read the article: First Seizures, Acute Repetitive Seizures, and Status Epilepticus Subscribe to Continuum: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @LyellJ  Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum, the premier topic-based neurology clinical review and CME journal from the American Academy of Neurology. Thank you for joining us on Continuum Audio, which features conversations with Continuum's guest editors and authors who are the leading experts in their fields. Subscribers to the Continuum journal can read the full article or listen to verbatim recordings of the article and have access to exclusive interviews not featured on the podcast. Please visit the link in the episode notes for more information on the article, subscribing to the journal, and how to get CME. Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum: Lifelong Learning in Neurology. Today, I'm interviewing Dr Dave Vossler, who has recently authored an article on emergent seizure management, taking care of patients with the first seizure, acute repetitive seizures, and status epilepticus, which is an article in our latest issue of Continuum covering all topics related to epilepsy. Dr Vossler is a neurologist at the University of Washington, where he's a clinical professor of neurology and has an active clinical and research practice in epileptology. Dr Vossler, welcome. Thank you for joining us today. Why don't you introduce yourself to our listeners? Dr Vossler: Thank you very much for the introduction, Lyell. It's a pleasure to speak with you on this podcast, and I hope to go over a lot of important new information in the management of seizure emergencies. As you said, I'm a clinical professor in neurology at University of Washington, been in medicine for many decades now and have published and done research in this area. So, I'm anxious to give you not only my academic experience, but also talk about my own management of patients with status epilepticus over the last four decades. Dr Jones: Yeah, that's fantastic. And I always appreciate hearing from experienced clinicians, and I think our readers and our listeners do appreciate that voice of clinical expertise. And I'll tell you this is a topic, you know, as a neurologist who doesn't see many patients with acute seizure emergencies in my own practice, I think this is a topic that gives many clinicians, including neurologists, some anxiety. Your article, Dr Vossler, is really chock-full of helpful and clinically relevant considerations in the acute management of seizures. So, you now have the full attention of a huge audience of mostly neurologists. What's the one most important practice change that you would like to see in the care of patients with either first or acute prolonged seizures? Dr Vossler: Without a doubt, the most important clinical takeaway with regard to the status epilepticus---and for status epilepticus, many, many clinical trials, research trials have been done over the last couple decades and they all consistently show the same thing, that by and large most patients who have status epilepticus are underdosed and undertreated and treated too slowly in the initial stages of the status epilepticus. And it's important to use full bolus dosages of benzodiazepines to prevent mortality, morbidity, and later disability of these patients. To prevent the respiratory depression, many physicians are afraid to use higher doses of benzodiazepines, even guideline-recommended doses of benzodiazepines for fear of respiratory depression. But it's actually counterintuitive. It turns out that most cases of respiratory depression are due to inadequate doses and due to the status epilepticus itself. We know there's greater mortality, we know there's greater morbidity and we know that there's greater need for higher dose, subsequent, anti-seizure medications, prolonged status, if we don't use the proper doses. So, we'll kind of go over that a little bit, but that is the one clinical takeaway that I really would like our listeners to have. Dr Jones: Let's follow that thread a little bit. Dave, I know obviously we will speak in hypotheticals here. We're not going to talk about actual patients, but I think we've all been in the clinical situation where you have a patient who comes into the emergency room usually who's actively seizing, unknown history, don't know much about the patient, don't know much about the circumstances of the onset of the seizure. But we now have a patient with prolonged convulsive seizures. How do we walk through that? What are the first steps in the management of that patient? Dr Vossler: Yeah, well, I'll try to be brief for the purposes of the podcast. We do, of course, go through all of that in detail in the Continuum article, which hopefully everybody will look at very carefully. Really in the first table, the very first table of the article, I go through the recommended guideline for the American Epilepsy Society on the management of what we call established status epilepticus. The scenario you're talking about is just exactly that: established status epilepticus. It's not sort of evolving or developing status. We're okay they're having a few seizures and we're kind of getting there. No, this patient is now having evidence of convulsive seizure activity and it's continuing or it's repeated seizures without recovery. And so, the first phase is definitely a benzodiazepine and then the second phase is then a longer-acting bolus of a drug like phosphenotoine, valproic acid or levetiracetam. I could get into the details about dosing of the benzodiazepines, but maybe I'll let you guide me on whether we wanted to get into that kind of detail right at the outset. It's going to be a little bit different. For children, its weight-based dosing, but for adults, whether you use lorazepam or you use diazepam or you use midazolam, the doses are a little bit different. But they are standardized, and gets back to this point that I made earlier, we're acting too slow. We're not getting these patients quick enough, for various reasons, and the doses that are most commonly used are below what the guidelines call for. Dr Jones: That's great to know, and I think it's fine for the details to refer our listeners to the article because there are great details in there about a step-by-step approach to the established status epilepticus. The nomenclature and the definitions have evolved, haven't they, Dr Vossler, over time? Refractory status epilepticus, new-onset refractory status epilepticus, super refractory status epilepticus. Tell us about those entities, how they're distinguished and how you approach those. Dr Vossler: That's an important thing to kind of go over. They- in 2015, the International League Against Epilepsy, ILAE, which is, again, our international organization that guides our understanding of all kinds of things epileptic in nature around the world. In 2015 they put out a definition of status epilepticus, but it used to be that patients had thirty minutes of continuous seizure activity or repetitive obvious motor seizures with impairment of awareness and they don't recover impairment between these seizures. And that goes on for thirty minutes. That was the old definition of status epilepticus. Now, the operational definition is five minutes. And I think that's key to understand that, after five minutes of this kind of overt seizure activity, you need to intervene. And that's what's called T1 in the 2015 guideline, the international guideline. There are a bunch of different axes in the classification of status that talk about semiology, etiology, EEG patterns, and what age group you're talking about. We won't really get into those in the Continuum article because that's really more detailed than a clinician really should be. Needing to think about the stages, what we call the stages of status epilepticus that you mentioned and I alluded to earlier are important. And that is sort of new nomenclature, and I think probably general neurologists and most emergency room physicians aren't familiar with those. So, it just briefly goes through those. Developing status epilepticus is where you're starting- the patient's starting to have more frequent seizures, and it's heading essentially in the wrong direction, if you will. Established status epilepticus, as I mentioned, is, you know, this seizure act, convulsive or major, major outward overt seizure activity lasting five minutes or more, at which time therapy needs to begin. Again, getting back to my point, what doesn't happen often enough is we're not- we're intervening too late. Third is refractory status epilepticus, which refers to status epilepticus which continues despite adequate doses of an initial benzodiazepine given parenterally followed by a full loading dose of a single non-sedating anti-seizure medicine, which today includes phosphenotoine IV valproic acid or IV levetiracetam. In the United States, and increasingly around the world, people really are using levetiracetam. First, it has some advantages. There's now proof from a class one NIH-funded trial. We know that these three drugs are equivalent at the full doses that I go over in the article. You have your kind of dealer's choice on those. Phenobarbital, which we used to use and I used as a resident as long as forty years ago, is really a second choice drug because of its sedating and other side effects. But around the world in resource-poor countries phenobarbital can be used and, in a pinch, certainly is an appropriate drug. And then finally, you mentioned super refractory status epilepticus and that's status that's persisting for more than twenty four hours. Now, despite initial benzo and non-sedating anti-seizure medicine, but also lasting more than twenty four hours while receiving an intravenous infusional sedating, anesthetizing anti-seizure medicine like ketamine, propofol, pentobarbital or midazolam drips. Dr Jones: So, it sounds like the definitions have evolved in a way that improves the outcomes, right? To do earlier identification of status epilepticus and more aggressive management, I think that's a great takeaway. If we move all the way to the other end of the spectrum, let's move to the ambulatory setting and we have a patient who comes in and they've had one seizure, they're an adult; one seizure, the first seizure. The key question is, how do we anticipate the risk of future seizures? But walk us through how you talk to that patient, how you evaluate that patient to decide if and when to start anti-seizure medicines. Dr Vossler: Well, it depends a little bit if it's an adult or a child, but the decision making process and the data behind it is pretty robust now. And the decision making process is pretty similar for adults and children, with some differences which I can talk about. First of all, first seizures. I think it's really important to stress that there's been so much research in this area. I'd like to get a cross point that they're not as innocuous as I think many general neurologists might suspect. We know that there is a two- to threefold increased risk of death in children and adults following a first seizure. Moreover, the risk of a second seizure, both in kids and adults, is about 36% two years after that first seizure. It's about 46% five years after that first seizure. It's really pretty substantial. The risk of a second seizure is increased twofold. It doubled in the presence of any kind of a history of prior brain insults that could result in seizures. Could be infections, it could be a prior stroke, it could be prior significant brain trauma. It's also doubled in the presence of an EEG, which shows epileptiform discharges like spikes and sharp waves---and not just a sort of borderline things like sharply contoured rhythmic Theta activity. That's really not what we're talking about. We're talking about overt epileptiform discharges. It's doubled in the presence of lesion that can be seen on imaging studies, and it's doubled in the presence of seizures if that first seizure occurs during sleep. So, we have a number of things that double the risks, above the risk of a second seizure, above that 36% at two years and 46% at five years that I spoke about. And so those things need to be considered when you're counseling a patient about that. Should you be on an anti-seizure medicine after that first seizure? Specifically, to the point of anti-seizure medications, the guideline that was done, the 2015 guideline that was done by the American Academy of Neurology for adults, and the 2003 guideline was actually a practice parameter that was done by the Academy and the American Epilepsy Society for children, are really kind of out of date. They talk about the adverse effects of anti-seizure medications, but when you look back at the studies that were included in developing that practice parameter for kids and guidelines for adults, they are the old drugs: carbamazepine, phenytoin, phenobarbital and valproate. Well, I don't think I need to tell this audience, this well-educated audience, that we don't use those drugs anymore. We are using more modern anti-seizure medicines that have been developed since 1995; things like lamotrigine, levetiracetam, and lecosamide. Those three in particular have very low adverse events. So, the guideline that the Academy, American Academy Neurology and American Epilepsy Society put together for kids and for adults talks about this high adverse event profile. And so, you need to take a look at the risks that I talked about of a seizure recurrence and balance that against adverse effects. But I'm here to tell you that the newer anti-seizure medicines---and by newer I'm talking in the last thirty years since lamotrigine was approved in 1995---these drugs have much better side effect profiles. And I think all epileptologists would agree with that. They're not necessarily more effective, but they are better tolerated. That makes the discussion of the risk of a second seizure, the risk of mortality versus side effects of drugs, it really pushes the risk category higher on the first side and not on the side of drugs. We know that if you take an anti-seizure medicine, you reduce your risk of a second seizure by half. Now, that's not sustained over five years, but over the first two years, you've reduced it by half. In a person who's driving, needs to get to work, has to take the kids to school, whatever, most of my patients are like, yeah, okay, sign me up. These drugs are really pretty well tolerated. There's a substantial risk of a second seizure. So, I'll do that. In a kid,  a child that's, you know, not driving yet, that might be a different discussion. And the parents might say, well, I'd rather not have my son exposed, my daughter exposed to this. They're trying to go to school. They're trying to learn. We don't want to hinder that. We'll wait for a second seizure and then if they have a second seizure, which by the way is, you know, one of the definitions of epilepsy, well then they have epilepsy, then they probably will need to go on the seizure medication. Dr Jones: Great summary, Dr Vossler, and it is worth our audience being aware that the evidence has evolved alongside the improvement in the adverse effect profile. And sounds like your threshold is a little lower to treat then maybe it would have been some time ago, right? Dr Vossler: I would say that's exactly correct in my opinion. Particularly for adults, absolutely. Dr Jones: That's fantastic, Dr Vossler. I imagine there are a lot of aspects of caring for these patients that are challenging, and I imagine many scenarios are actually pretty rewarding. What do you find the most rewarding aspect of caring for patients with acute seizure management? Dr Vossler: Yes, I mean, that is really true. I would say that the most challenging things are treating refractory status epilepticus, but worse yet, new onset refractory status epilepticus and the super refractory status epilepticus, which I talk extensively about or write extensively about in the article and provide a lot of guidance on. Really, those conditions are so challenging because they can go on for such a long time. Patients are hospitalized for a long time. A lot of really good clinical guidance doesn't exist yet. There is a tremendous amount of research in that area which I find exciting, and really there's an amazing amount of international research on that, I think most of our audience probably is unaware of. And certainly, with those conditions, there is a high risk of later disability and mortality. We go through all of that in the article. The rewards really come from helping these people. When someone was super refractory status and it were non- sorry, new onset refractory status epilepticus, has been in the hospital for thirty days, it gets really hard for everybody; the family, the patient. And for us, it wears on us. Yet when they walk out the door, and I've had these people come back to the epilepsy clinic and see me later. We're managing their anti-seizure medications. They've survived. The NORSE patients often have substantial disability. They have cognitive and memory and even some psychiatric disability. But yet we can help them. It's not just management in the hospital, but it's getting to know these people, and I take them from the hospital and see them in my clinic and manage them long-term. I get a lot of great satisfaction out of that. We're hoping to do even better, stop patients' status early and get them to recover with no sequelae. Dr Jones: What a great visual, seeing those patients who have a devastating problem and they come back to clinic and you get the full circle. And what a great place to end. Dr Vossler, thank you so much for joining us, and thank you for such a thorough and fascinating discussion on the importance of understanding and managing patients with the first seizure, acute repetitive seizures, and status epilepticus. Dr Vossler: Thank you very much, Lyell. Dr Jones: Again, we've been speaking with Dr Dave Vossler, author of an article on emergent seizure management, first seizures, acute repetitive seizures and status epilepticus in Continuum's most recent issue on epilepsy. Please check it out, and thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

The Americans with Disabilities Act is unquestionably in the premiere class of landmark legislation in American History. On this episode, Greg sits down with the original author and co-sponsor of the ADA -- avid disability rights advocate, the Honourable Tony Coelho, former Representative from California. Tony first introduced the ADA alongside Senator Lowell Weicker in the 100th Congress in 1988 and battled the red tape, opposition and criticism to finally get the bill passed and signed into law by President George H.W. Bush in 1990.  Greg is joined by his Talk About It partner Ken Lowenberg to talk with Tony about his personal history with epilepsy, how the bill came into existence, the importance of enforcing the ADA by presidential administrations, and the dangers of stigma. This episode is so important to listen to, because it's easy to overlook how widespread the impact of the ADA is, touching every American in ways that might be subtle or even hidden. Don't miss it! The Talk About It podcast is excited to be sponsored in part by Neurelis. The Talk About It podcast is excited to sponsored in part by Seizures Are Signs — dedicated to educating families on the importance of early and specific diagnosis by providing an assessment to help get the conversation started, educational information, stories from families who have found a diagnosis, links to advocacy groups, and more. For more information, go to SeizuresAreSigns.com. Seizures are Signs is made available by Jazz Pharmaceuticals.

Seized machines from Bitcoin miners are slowly being released. Is that the Trump affect or is more to come?You're listening to The Mining Pod. Subscribe to the newsletter, trusted by over 8,000 Bitcoiners: https://newsletter.blockspacemedia.comWant to mine Bitcoin? Check out the Blockspace Media store today!Welcome back to The Mining Pod! Today, hosts Colin and Will dive into the ongoing saga of US Customs and Border Protection seizing Bitcoin mining hardware at various ports of entry. Initially targeting Antminer units in late 2024, the seizures expanded to include equipment from Whatsminer and Canaan, costing some companies millions in detained assets. The hosts explore how industry lobbying - particularly through Senator Lummis and connections to the Trump administration - has begun to resolve the situation, along with theories about why these unprecedented seizures occurred in the first place. Could this push more manufacturing onshore?Notes:- $5 million worth of hardware seized from one company- Seizures expanded beyond Antminer to Whatsminer/Canaan- Detentions began Sep 2024, escalated to seizures Feb 2025- Shipments being released after industry lobbying- Sen. Lummis and White House helped resolve situation- CBP cited unauthorized communications equipment lawsTimestamps:00:00 Start02:17 History of seizure trend09:08 Lobbying the government for release17:42 Follow on effects20:13 Bitmain plans24:20 Conspiracy corner: Evil or Entropy

You're listening to The Mining Pod. Subscribe to the newsletter, trusted by over 8,000 Bitcoiners: https://newsletter.blockspacemedia.com Want to mine Bitcoin? Check out the Blockspace Media store today! Welcome back to The Mining Pod! Today, hosts Colin and Will dive into the ongoing saga of US Customs and Border Protection seizing Bitcoin mining hardware at various ports of entry. Initially targeting Antminer units in late 2024, the seizures expanded to include equipment from Whatsminer and Canaan, costing some companies millions in detained assets. The hosts explore how industry lobbying - particularly through Senator Lummis and connections to the Trump administration - has begun to resolve the situation, along with theories about why these unprecedented seizures occurred in the first place. Could this push more manufacturing onshore? Timestamps: 00:00 Start 02:17 History of seizure trend 09:08 Lobbying the government for release 17:42 Follow on effects 20:13 Bitmain plans 24:20 Conspiracy corner: Evil or Entropy Notes: - $5 million worth of hardware seized from one company - Seizures expanded beyond Antminer to Whatsminer/Canaan - Detentions began Sep 2024, escalated to seizures Feb 2025 - Shipments being released after industry lobbying - Sen. Lummis and White House helped resolve situation - CBP cited unauthorized communications equipment laws

Everybody needs a Jonathan Shapiro in their life. In this special season premiere of Talk About It, Greg sits down with his closest mensch and the other half of his party of two at the deli, Jonathan Shapiro. When life gets hard, Greg turns to him for sage advice and a nice bowl of matzoh ball soup. As you'll find out in this episode, Jonathan has quite a personal history, beginning his career as a federal prosecutor and eventually becoming... you guessed it... a television show writer and showrunner. (BOSTON LEGAL, THE PRACTICE, GOLIATH, THE BLACKLIST, among many others.)  Not only that, Jonathan has a deep personal connection to Greg because he is also the father of a son with epilepsy, the incredible Zeke Shapiro. The two mensches talk about Zeke's journey with his condition, and his abject bravery to perform stand up comedy and become a news anchor. They have always - and will continue to - lean on each other when times are really hard, or celebrate together when times are really great, and everything in between. All over a tuna melt on rye heels, of course. You don't want to miss this episode! The Talk About It podcast is excited to be sponsored in part by Neurelis. The Talk About It podcast is excited to sponsored in part by Seizures Are Signs — dedicated to educating families on the importance of early and specific diagnosis by providing an assessment to help get the conversation started, educational information, stories from families who have found a diagnosis, links to advocacy groups, and more. For more information, go to SeizuresAreSigns.com. Seizures are Signs is made available by Jazz Pharmaceuticals.  

The CBP is seizing ASIC miners at the border, and Chinese tech giant Tencent adds to its bitcoin mining exposure.You're listening to The Mining Pod. Subscribe to the newsletter, trusted by over 8,000 Bitcoiners: https://newsletter.blockspacemedia.comWelcome back to The Mining Pod! For this week's news roundup, Colin and Matt talk about the big story Blockspace broke this week: the U.S. Customs and Border Protection agency is seizing Antminer ASICs at ports of entry, and it's also started to detain MicroBT and Canaan units. Plus, the $500 billion Chinese tech giant Tencent ups its stake in newly-christened public bitcoin miner Cango to 15.6%. They also touch on Bit Digital's WhiteFiber AI rebrand, and why Riot's newest board member signals that it's getting increasingly serious about an AI pivot. The duo also welcomes Luxor Director of Energy Trading Haley Thomson to discuss what the AI boom means for Texas power prices. And for this week's cry corner: bitcoin obituaries are dead – all hail number go up.Notes:• BitaxeOpen Source Project• 256 Foundation Mission• Breaking Mining Monopolies• Standardized Hash Boards• DIY Mining Innovation• Hardware DemocratizationTimestamps00:00 Start01:59 Telehash & hitting block05:26 Intros12:51 256 Foundation mandate?16:02 BitAxe users18:53 AmberOne project22:08 Designer BitAxe culture27:24 Mining centralization

حملات عصبی به شکل‌های مختلف بروز می‌کنند و بسته به نوع اختلالات روانی یا عصبی، می‌توانند متفاوت باشند. در این اپیزود ۸ حمله عصبی زیر را توضیح می دهم: 1. حملات پانیک (Panic Attacks) 2. حملات اضطرابی (Anxiety Attacks)  3. حملات هیستریک (Hysterical Attacks) 4. حملات عصبی مرتبط با استرس پس از سانحه (PTSD Attacks) 5. حملات عصبی هیپوگلیسمیک (Hypoglycemic Attacks) 6. حملات مرتبط با اختلال اضطراب اجتماعی (Social Anxiety Attacks) 7. حملات عصبی شبه‌تشنج (Non-epileptic Seizures) 8. حملات عصبی تنفسی (Hyperventilation Attacks) در مورد حمله پنیک این را هم اضافه می کنم که حملات پانیک شامل ترکیبی از علائم فیزیکی و روانی است که به‌طور ناگهانی و شدید بروز می‌کند. برخی از علائم رایج عبارتند از: 1. تپش قلب شدید یا افزایش ضربان قلب 2. تعریق بیش‌ازحد 3. لرزش یا رعشه 4. تنگی نفس یا احساس خفگی 5. درد یا ناراحتی در قفسه سینه 6. سرگیجه یا احساس ضعف 7. ترس از مرگ یا دیوانگی 8. احساس جدایی از بدن (دپرسونالیزیشن) لطفا شما هم تجربیاتتون رو در کامنت بنویسید، مرسی Sep   نسخه تصویری را در یوتیوب ببینید https://youtube.com/@sepblog